HSBC Holdings
IRWD icon

HSBC Holdings’s Ironwood Pharmaceuticals IRWD Stock Holding History

HSBC Holdings’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$542K Buy
126,100
+96,394
+324% +$372K ﹤0.01% 2243
2026
Q1 		$104K Buy
29,706
+6,270
+27% +$25.7K ﹤0.01% 2747
2025
Q4 		$78.9K Buy
+23,436
New +$60.9K ﹤0.01% 2823
2025
Q3 		– Sell
-12,351
Closed -$8.69K – 2923
2025
Q2 		$8.69K Sell
12,351
-8,427
-41% -$6.62K ﹤0.01% 2998
2025
Q1 		$29.9K Sell
20,778
-108
-0.5% -$257 ﹤0.01% 2949
2024
Q4 		$91.4K Buy
20,886
+9,828
+89% +$39.9K ﹤0.01% 2906
2024
Q3 		$43.1K Sell
11,058
-14,865
-57% -$79.9K ﹤0.01% 2893
2024
Q2 		$167K Buy
25,923
+9,740
+60% +$68.9K ﹤0.01% 2618
2024
Q1 		$141K Sell
16,183
-13,474
-45% -$163K ﹤0.01% 2766
2023
Q4 		$338K Sell
29,657
-227,144
-88% -$2.25M ﹤0.01% 2228
2023
Q3 		$2.47M Buy
256,801
+10,294
+4% +$101K ﹤0.01% 1359
2023
Q2 		$2.63M Sell
246,507
-3,650
-1% -$39.2K ﹤0.01% 1326
2023
Q1 		$2.64M Buy
250,157
+108,020
+76% +$1.21M ﹤0.01% 1400
2022
Q4 		$1.76M Buy
142,137
+75,962
+115% +$862K ﹤0.01% 1741
2022
Q3 		$692K Sell
66,175
-47,644
-42% -$540K ﹤0.01% 2011
2022
Q2 		$1.31M Buy
113,819
+91,019
+399% +$1.07M ﹤0.01% 1788
2022
Q1 		$286K Sell
22,800
-23,134
-50% -$265K ﹤0.01% 2782
2021
Q4 		$539K Buy
45,934
+2,817
+7% +$34.6K ﹤0.01% 2414
2021
Q3 		$566K Sell
43,117
-11,430
-21% -$148K ﹤0.01% 2189
2021
Q2 		$705K Buy
54,547
+28,398
+109% +$325K ﹤0.01% 1961
2021
Q1 		$291K Sell
26,149
-6,087
-19% -$64.3K ﹤0.01% 2315
2020
Q4 		$367K Buy
32,236
+16,096
+100% +$176K ﹤0.01% 2427
2020
Q3 		$146K Sell
16,140
-23,509
-59% -$234K ﹤0.01% 2558
2020
Q2 		$409K Buy
+39,649
New +$406K ﹤0.01% 1958
2020
Q1 		– Sell
-50,624
Closed -$675K – 2855
2019
Q4 		$675K Sell
50,624
-22,969
-31% -$253K ﹤0.01% 2059
2019
Q3 		$632K Buy
+73,593
New +$715K ﹤0.01% 2196
2017
Q1 		– Sell
-26,611
Closed -$341K – 2349
2016
Q4 		$341K Buy
+26,611
New +$336K ﹤0.01% 2135

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

HSBC Holdings's IRWD Position: Q2 2026 in Review

HSBC Holdings increased its Ironwood Pharmaceuticals (IRWD) stake by 324% in Q2 2026, buying an estimated $372K and bringing the position to 126,100 shares worth $542K. The position accounts for ﹤0.01% of the portfolio, ranked #2243.

HSBC Holdings first reported a position in IRWD in Q4 2016 and has held it in 27 quarters since. The position peaked at $2.64M in Q1 2023. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • HSBC Holdings held 126,100 shares of Ironwood Pharmaceuticals worth $542K as of Q2 2026.
  • HSBC Holdings bought 96,394 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $372K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2243 holding.
  • HSBC Holdings first reported a position in Ironwood Pharmaceuticals in Q4 2016 and has held it in 27 quarters since.
  • HSBC Holdings's Ironwood Pharmaceuticals position peaked at $2.64M in Q1 2023.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.